Nautilus Biotechnology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Nautilus Biotechnology stock has a target of 4.00, which predicts an increase of 100.00% from the current stock price of 2.00.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$4.00	$4.00	$4.00
Change	+100.00%	+100.00%	+100.00%	+100.00%

* Price targets were last updated on Apr 29, 2026.

Analyst Ratings

The average analyst rating for Nautilus Biotechnology stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Oct '25	Dec '25	Jan '26	Feb '26	Apr '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Subbu Nambi Guggenheim	Guggenheim	Buy Reiterates $4	Buy	Reiterates	$4	+100.00%	Apr 29, 2026
Daniel Brennan TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Apr 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

700.00K

Revenue Next Year

7.65M

from 700.00K

992.86%

from 700.00K

EPS This Year

-0.61

from -

EPS Next Year

-0.60

from -0.61

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	700.00K	7.65M
Revenue Growth	-	-	-	-	-	-	992.86%
EPS	-0.60	-0.46	-0.51	-0.56	-0.47	-0.52	-0.52
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	900,000	10.5M
Avg	700,000	7.7M
Low	500,000	4.8M

Revenue Growth

Revenue Growth	2027	2028
High	1,400.0%	292.2%
Avg	992.9%	292.2%
Low	585.7%	292.2%

EPS Forecast

EPS	2026	2027
High	-	-
Avg	-0.61	-0.60
Low	-	-

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.